BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34196279)

  • 1. New-onset thyrotoxicosis in a patient with anaplastic thyroid carcinoma: a diagnostic challenge.
    Concepción Zavaleta MJ; Ildefonso Najarro SP; Plasencia Dueñas EA; Quispe Flores MA; Moreno Marreros DM; Concepción Urteaga LA; Luna Victorio LE; Fernández Dávila FV
    Endocrinol Diabetes Metab Case Rep; 2021 Jul; 2021():. PubMed ID: 34196279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaplastic thyroid carcinoma with rapid thyrotoxicosis - a case report and the literature review.
    Daroszewski J; Paczkowska K; Jawiarczyk-Przybyłowska A; Bolanowski M; Jeleń M
    Endokrynol Pol; 2018; 69(1):28-31. PubMed ID: 29319130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA typing of patients who developed subacute thyroiditis and Graves' disease after SARS-CoV-2 vaccination: a case report.
    Yasuda S; Suzuki S; Yanagisawa S; Morita H; Haisa A; Satomura A; Nakajima R; Oikawa Y; Inoue I; Shimada A
    BMC Endocr Disord; 2023 Mar; 23(1):54. PubMed ID: 36879263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graves' disease in a mediastinal mass presenting after total thyroidectomy for nontoxic multinodular goiter: a case report.
    Cunha FM; Rodrigues E; Oliveira J; Saavedra A; Vinhas LS; Carvalho D
    J Med Case Rep; 2016 Mar; 10():70. PubMed ID: 27029843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaplastic pseudothyroiditis.
    Basaria S; Udelsman R; Tejedor-Sojo J; Westra WH; Krasner AS
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):553-5. PubMed ID: 11966749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaplastic thyroid carcinoma with thyrotoxicosis and hypoparathyroidism.
    Heymann RS; Brent GA; Hershman JM
    Endocr Pract; 2005; 11(4):281-4. PubMed ID: 16006301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poorly Differentiated Thyroid Carcinoma Coexisting with Graves' Disease Involving T3 Thyrotoxicosis due to Increased D1 and D2 Activities.
    Okazaki-Hada M; Maruoka A; Yamamoto M; Ito M; Hirokawa M; Nishikawa M; Akamizu T; Miyauchi A; Toyoda N
    Thyroid; 2021 Oct; 31(10):1592-1596. PubMed ID: 34278816
    [No Abstract]   [Full Text] [Related]  

  • 8. Anaplastic thyroid carcinoma diagnosed after treatment of lenvatinib for papillary thyroid carcinoma.
    Yamazaki H; Iwasaki H; Suganuma N; Toda S; Masudo K; Nakayama H; Rino Y; Masuda M
    Endocrinol Diabetes Metab Case Rep; 2019 Oct; 2019():. PubMed ID: 31600721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid metastasis of endometrial carcinosarcoma associated with Graves' disease.
    Mete O; Ozbey N; Erbil Y; Salmasloglu A; Aral F; Temel B; Dizdaroglu F
    Gynecol Endocrinol; 2007 Oct; 23(10):562-6. PubMed ID: 17852422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating Graves' disease from subacute thyroiditis using ratio of serum free triiodothyronine to free thyroxine.
    Sriphrapradang C; Bhasipol A
    Ann Med Surg (Lond); 2016 Sep; 10():69-72. PubMed ID: 27570620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous occurrence of subacute thyroiditis and Graves' disease.
    Hoang TD; Mai VQ; Clyde PW; Shakir MK
    Thyroid; 2011 Dec; 21(12):1397-400. PubMed ID: 22136271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent Subacute Thyroiditis and Graves' Disease After COVID-19: A Case Report.
    Nham E; Song E; Hyun H; Seong H; Yoon JG; Noh JY; Song JY; Cheong HJ; Kim WJ
    J Korean Med Sci; 2023 May; 38(18):e134. PubMed ID: 37158771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of thyrotoxicosis.
    Hennessey JV
    Am Fam Physician; 1996 Sep; 54(4):1315-24. PubMed ID: 8816575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves' disease.
    Ota H; Amino N; Morita S; Kobayashi K; Kubota S; Fukata S; Kamiyama N; Miyauchi A
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):41-5. PubMed ID: 17437515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute suppurative thyroiditis with Graves disease - A very rare association.
    Damásio I; Maciel J; Costa MM; Raimundo L
    Arch Endocrinol Metab; 2023 May; 67(5):e000610. PubMed ID: 37249449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple and practical parameters for differentiation between destruction-induced thyrotoxicosis and Graves' thyrotoxicosis.
    Izumi Y; Hidaka Y; Tada H; Takano T; Kashiwai T; Tatsumi KI; Ichihara K; Amino N
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):51-8. PubMed ID: 12100069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid thyrotoxicosis in anaplastic thyroid carcinoma.
    Phillips JS; Pledger DR; Hilger AW
    J Laryngol Otol; 2007 Jul; 121(7):695-7. PubMed ID: 17156585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graves' disease with only unilateral involvement; a case report.
    Bu Bshait MS
    Int J Surg Case Rep; 2024 Jan; 114():109138. PubMed ID: 38086135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaplastic thyroid cancer: prevalence, diagnosis and treatment.
    Chiacchio S; Lorenzoni A; Boni G; Rubello D; Elisei R; Mariani G
    Minerva Endocrinol; 2008 Dec; 33(4):341-57. PubMed ID: 18923370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic.
    Ruggeri RM; Campennì A; Siracusa M; Frazzetto G; Gullo D
    Hormones (Athens); 2021 Mar; 20(1):219-221. PubMed ID: 32676935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.